IDH2 and glioma: Of interest, the combined evaluation of the T2w and FLAIR images (also known as “T2/FLAIR mismatch sign”) has recently emerged as a non-invasive biomarker of IDH-MUT 1p/19q non-codeleted gliomas (Figure 1).